Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant-Reference-Cited by-同舟云学术

Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant

Published:2020-11-03 Issue: Volume:7 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Piras Rossella,Iatropoulos Paraskevas,Bresin Elena,Todeschini Marta,Gastoldi Sara,Valoti Elisabetta,Alberti Marta,Mele Caterina,Galbusera Miriam,Cuccarolo Paola,Benigni Ariela,Remuzzi Giuseppe,Noris Marina

Publisher

Frontiers Media SA

Subject

General Medicine

Reference47 articles.

1. Hemolytic uremic syndrome;Noris;J Am Soc Nephrol.,2005

2. Atypical hemolytic-uremic syndrome;Noris;N Engl J Med.,2009

3. The pathogenesis and treatment of hemolytic uremic syndrome;Kaplan;J Am Soc Nephrol.,1998

4. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conference;Goodship;Kidney Int.,2017

5. Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy;Huemer;Orphanet J Rare Dis.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement Biosensors Identify a Classical Pathway Stimulus in Complement-Mediated Hemolytic Uremic Syndrome;2024-06-02

2. An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome;Frontiers in Immunology;2023-02-09

3. CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome;Frontiers in Immunology;2023-01-30

4. De novo systemic atypical hemolytic uremic syndrome in an ABO-incompatible living kidney transplant recipient with a novel pathogenic CFHR1 gene mutation successfully treated with eculizumab: a case report;Journal of Nephrology;2022-07-19

5. Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside;Frontiers in Immunology;2022-04-12